Status: Recruiting
Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma
COMPLEMENT study (ChrOnic subdural hematoMa Patients suppLemented with Embolization of Middle mENingeal artery Trial) is a prospective, open label, blinded endpoint (PROBE), Japanese, two-arm, randomized, controlled, post-market study to assess the efficacy and safety of middle meningeal artery embolization for chronic subdural hematoma.
Participants needed: 600
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kazutaka UchidaUpdated: May 28, 2025Locations: 1
Eligibility criteria
Age >=18 [+3]
Cr >=1.8 [+2]